Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

12.1.10

Asthma in Pregnancy

Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 12, Sexual and Reproductive Health.

Clinical Description

Reversible airway inflammation and bronchoconstriction.

Signs and Symptoms

  • Asthma is unpredictable in pregnancy: 1/3 of women report improvement, 1/3 remain the same, and 1/3 worsen.
  • Trigger (often viral), chest tightness, shortness of breath, cough, wheezing, tachypnea

Investigations

  • Peak flow meter or spirometry, pulse oximetry

Treatment

  • Avoid triggers and use inhaled corticosteroids to decrease underlying inflammation (for detailed information refer to O & G protocols and guidelines and MSTG respiratory conditions section).
  • Antenatal clinics visit monthly if on regular medication.
  • Avoid GERD in 3rd trimester by using Proton Pump Inhibitor or H2 blocker
  • Peak flow meter EVERY 12HRS (first thing in the morning and 12 hrs later) if available
  • For mild - moderate persistent asthma: salbutamol inhaler 1-2 puffs EVERY 8HRS or corticosteroid inhaler (i.e., beclomethasone)
  • For acute and/or severe exacerbations:
  • Admit to HDU
  • O2 therapy to keep SaO2 >95%
  • inhaled bronchodilator (salbutamol, ipromium bromide and normal saline) through a nebulizer or spacer every 10-20 min until improvement seen
  • IV fluids
  • IV Aminophylline 250 mg over 10 min or MGSo4 2g stat
  • Sit up
  • 4-hourly fetal monitoring
  • Systemic steroids (i.e. hydrocortisone or prednisone IV) for up to 5-7 days
  • Continuously assess response to treatment, complete response is resolution of symptoms and PEFR>80%
  • Incomplete response is continuation of symptoms PEFR<80% personal best
  • Urgent intervention required when PEFR <50% personal best
  • Indication for intubation and ventilation: inability to maintain respiratory drive, worsening hypercapnia, respiratory acidosis, confusion and inability to maintain SpO2> 95% despite high flow oxygen

Intrapartum management

  • Refer if at the health centre
  • continue regular inhaler prn
  • Use of IV hydrocortisone if patient has been on oral steroids >7.5mg/day for >2 weeks
  • 4-hourly fetal monitoring
  • Misoprostol if indication for labour induction
  • Oxytocin if PPH
  • Avoid use of PGF2 and Ergometrine

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.